Navigation Links
Excipients Help Pharma Extend Product Life, Profits
Date:4/2/2008

NEW YORK, April 2, 2008 /PRNewswire/ -- With their ability to extend product life, excipients are being turned to increasingly as part of Big Pharma's strategy during lean times, and this portends a robust market for them, according to a new report from a major life sciences market research publisher. There are about 1200 excipients on the market, used in all types of pharmaceuticals. This $4.6 billion market has witnessed healthy growth in the past few years and is expected to continue along the same trajectory through 2012, due to increased demand from new drug targets, new biological drugs, new formulations and synthetic agents, according to Kalorama Information's new report Pharmaceutical Excipients for Oral Formulations, 2nd Edition.

Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to pharmaceuticals, aid in drug development and innovation and help improve patent life, all at a lower cost.

The pharmaceutical industry continues to be weighed down by the pressure to cut costs, by generic competition, and a lack of innovation. In this environment, excipients are becoming a more important aspect in tablet manufacture than they were previously and are even helping to develop innovative drug formulations. For example, innovations in delivery, such as sustained release, allow pharmaceutical companies to extend the patent life on existing products.

"Once they were thought of as fillers, but today the line between active ingredients and excipients has blurred," notes Bruce Carlson, publisher of Kalorama Information. "As companies need to develop cost-cutting strategies, excipients are now thought of as functional materials rather than inactive bulking agents."

Kalorama Information's report Pharmaceutical Excipients for Oral Formul
'/>"/>

SOURCE Kalorama Information
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...arbon layer in which the carbon atoms are arranged...arbon nanotubes are rolled-up sheets of graphene, ...Graphene boasts some very special characteristics ...mal conductor, and reconciles such conflicting qua...graphene is impermeable to gases, which makes it i...
(Date:11/23/2009)...DesignC or p.(IDC)announcedtodaythatDr.BruceL.A.Ca...uccessfultrackrec or dinbiotechnologyexecutivemana...Genetics,inSeattle,WAandChiefScientificOfficeratNo...://www.newscom.com/cgi-bin/prnh/20091123/SF15228 )...Officercommented,"IamdelightedtowelcomeDr.BruceCar...
(Date:11/20/2009)... , , , , , , , ...f scientists from Washington University in St. Lou...Laboratory and Iowa State University has finished ... Click here for more information. , , ... , , , , , , , , , ...
(Date:11/20/2009)... Karolinska Development AB today,an...s entered into a,co-investment agreement with the ... Karolinska Development and used to invest in the ...and medical technology companies. EIF,has agreed t...he agreement,represents EIF,s largest single inves...
Breaking Biology Technology:Polymer with honeycomb structure 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3
...a, Inc. (Nasdaq:,GORX) (the "Company") announced t...ide of an audience as possible it has placed both ...mpany on its website at, http://www.GeoPharmainc.c...nvestors" section and that it will be speaking pub...he most recent research report issued by Andre Gar...
...utics, Inc. (CTI),(Nasdaq: CTIC ; MTAX) managemen...or Conference on Tuesday, February 12th at 1:15 PM... The presentation will also be webcast live with s...tion. The webcast can be accessed at, http://www.c... Investor Conference CTI Presentatio...
...s and clinicians understand life one cell at a ...f., Feb. 6 This year marks 10 years of,Guava Tech...-to-use,cellular analysis technologies directly to...inicians worldwide. Since 1998, the company has,ex...nificant milestones,including introduction of the ...
Other Biology Technology:Recent Research Reports and Near-Term Corporate Events 2Recent Research Reports and Near-Term Corporate Events 3Guava Technologies Celebrates Tenth Anniversary 2
(Date:11/23/2009)... , Not just birds, but also a few species of ...t Princeton University in the U.S. and at the Max ...rmany studied the migratory behaviour of the large...ionidae" with the help of mathematical models. The... as long distances of various kinds of bats evolve...
(Date:11/22/2009)...ncrease the likelihood of immune complications fol...al team of researchers reports in the November 22 ...e gene, called UGT2B17, is missing from the donor,...ts have a significantly greater risk of a serious ... which immune cells from the donor attack tissues ...
(Date:11/20/2009)...cientific and technological frontiers. The Nationa... that totals nearly $4.3 million for the diverse e...erican Recovery and Reinvestment Act of 2009. , ...vestigation of solar phenomena. Philip R. Goode, d...e capabilities of NJIT,s Big Bear Solar Observator...
Breaking Biology News(10 mins):We're off then: The evolution of bat migration 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Consumer Reports Swine Flu Survival Kit Prepares Consumers for Potentially Tough Flu Season This Fall 53558 1Consumer Reports Swine Flu Survival Kit Prepares Consumers for Potentially Tough Flu Season This Fall 53558 2Consumer Reports Swine Flu Survival Kit Prepares Consumers for Potentially Tough Flu Season This Fall 53558 3Consumer Reports Swine Flu Survival Kit Prepares Consumers for Potentially Tough Flu Season This Fall 53558 4Are Microbes Headed Back to School this Fall 3F 53556 1Are Microbes Headed Back to School this Fall 3F 53556 2Scientists Discover Origin of Malaria 4818 1Scientists Discover Origin of Malaria 4818 2Scientists Discover Origin of Malaria 4818 3
... a cell, a virus often becomes dormant, turning of... trigger from its environment. When that trigger i... proteins through built-in positive-feedback loops...dback, production of something stimulates more pro...r faster, growth.) If the viral environment were p...
...te that, on average, they make about 15 food- and ... is, they make more than 15 times that -- more tha...ell study, Brian Wansink, the John S. Dyson Profes...ll, observed, "So many food decisions are made on ...ny more food decisions than we are aware of, he sa...
...f research, scientists at The University of Texas ...in, in exquisite molecular detail, how the estroge... , In the Sept. 24 issue of the journal, Nature C...s and proteins thought to play a part in breast ca...ified potential molecular drug targets. , "It,s ...
Other Biology News:A simple feedback resistor switch keeps latent HIV from awakening 2A simple feedback resistor switch keeps latent HIV from awakening 3'Mindless autopilot' drives people to underestimate food decisions 2New path from estrogen to survival in breast cancer cells described 2New path from estrogen to survival in breast cancer cells described 3
Rabbit Anti-Vitronectin Polyclonal Antibody, Unconjugated from Abcam
...MT5 Arginine methylation is an irreversible post ... been linked to protein activity. At least three t...lian cells. These enzymes have been shown to have ...ey proteins in several fundamental areas. These pr...
...is the major proteolytic system in the cytosol of ... degradation of short-lived regulatory proteins an...conformation (Hershko & Ciechanover 1998; Hochstra...is the 26S proteasome, an ATP-dependent proteolyti...
Rat Hair Follicle Stem Cell Culture from Celprogen
Biology Products: